Woman of Strength
WOMAN OF STRENGTH
Woman of Strength features two powerful, clinically studied ingredients, LJ100 and Libifem, that offer excellent support for women’s health, vitality and sexual desire. On the list of sexual vitality ingredients, one ingredient stands out from all the rest: Tongkat Ali. Tongkat Ali has been called Malaysian ginseng and is extensively consumed for its sexual support qualities. LJ100® is made from wild-crafted Tongkat Ali root, also called Longjack (botanical name: Euycoma longifolia) which is sourced from the rainforests of Malaysia by using sustainable harvesting and fair-trade practices. LJ100® is produced using a patented extraction technology which is standardized to 1% eurycomanone. LJ100 is produced by using only water as the extraction method. This method is preferred because previous tests using other solvents for extraction produced unwanted secondary compounds that were toxic. Thus LJ100 is sought after for its ability to support sexual vitality and desire in both women and men. Some believe that Tongkat Ali is the ultimate adaptogen.
The second ingredient is-patent-pending standardized fenugreek extract called Libifem® which has been clinically studied for its benefits to promote healthy menopause comfort and also healthy sexual desire. Libifem® is made from fenugreek seeds which naturally contain over 100 phytochemical constituents, including steroidal saponins and furostanol saponins. In fact, fenugreek seeds have been used for centuries to support female health, including sexual desire. Libifem® fenugreek extract has been clinically shown to help alleviate normal symptoms of menopause, including the reduction of hot flashes and night sweats. This extract also been clinically shown to promote healthy female sexual vitality and sexual desire. Thus, this herbal extract helps promote a healthy quality of life during menopause. One clinical study was conducted to assess the effectiveness of Libifem® fenugreek extract on normal symptoms of menopause in healthy women. This 12-week, double-blind, randomized, placebo-controlled clinical trial was conducted with healthy women (between the ages of 40 to 65 years) who were experiencing common symptoms of menopause, such as hot flashes and night sweats. The results showed reductions in menopausal symptoms in all sub-domains (vasomotor, psychosocial, physical and sexual). A second clinical trial (placebo-controlled, randomized, double blind) studied 80 healthy women of menstruating age (ages 20 to 49 years) for 8 weeks who were in stable relationships. The results of the study showed the effectiveness of Libifem in supporting healthy female sexual desire and experience.